Satsuma Pharmaceuticals
$13.939876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.08 (+17.55%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours
Why Robinhood?
You can buy or sell STSA and other stocks, options, ETFs, and crypto commission-free!
About STSA
Satsuma Pharmaceuticals, Inc. Common Stock, also called Satsuma Pharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA.
Employees
—
Headquarters
San Francisco, California
Founded
2016
Market Cap
205.91M
Price-Earnings Ratio
0.00
Dividend Yield
—
Average Volume
76.59K
High Today
$13.96
Low Today
$11.82
Open Price
$11.82
Volume
71.96K
52 Week High
$19.90
52 Week Low
$8.61
Collections
STSA Earnings
-$2.71
-$2.41
-$2.11
-$1.81
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 12, After Hours